Research progress of BANCR in papillary thyroid carcinoma

doi:10.3877/cma.j.issn.1674-3946.2021.02.031

Abstract

Abstract:

BRAF-activated non-coding RNA-BANCR has been found to express abnormally and play an important role in a variety of malignant tumors. In recent years, the expression of BANCR in papillary thyroid carcinoma (PTC) was reported, and its clinical significance and mechanism were explored. However, the results of different studies vary widely. This paper summarizes the relevant research on the mechanism of BANCR in PTC, in order to sort out and analyze the previous research results and controversy, and to provide reference for further research on the mechanism of BANCR in PTC.

Key words: Thyroid neoplasms, Carcinoma, papillary, RNA, Long non-coding RNA

Shaolong Hao, Jihong Ma, Wei Han. Research progress of BANCR in papillary thyroid carcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(02): 232-234.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhpwkssxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3946.2021.02.031

https://zhpwkssxzz.cma-cmc.com.cn/EN/Y2021/V15/I02/232

References 28

[1]	Freddie B, Jacques F, Isabelle S, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA CANCER J CLIN, 2018, 68: 394-424.
[2]	Nickel B, Tan T, Cveji E, et al. Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment[J]. JAMA Otolaryngol-Head Neck Surgery.2019, 145(3): 231-238.
[3]	Iyer MK, Niknafs YS, Malik R, et al. The landscape of long noncod-ing RNAs in the human transcriptome[J]. Nat Genet, 2015, 47 (3): 199-208.
[4]	Zhang Y-Z, Xu T, Cui D, et al. Value of TIRADS, BSRTC and FNA-BRAF^V600E mutation analysis in differentiating high-risk thyroid nodules[J]. Sci Rep, 2015, 5: 16927.
[5]	Gandolfi G, Sancisi V, Piana S, et al.Time to re-consider the meaning of BRAF^V600E mutation in papillary thyroid carcinoma [J]. Int J Cancer, 2015, 137(5): 1001-1011.
[6]	Alzahrani AS, Xing MZ. Impact of Iymph node metastases identified on central neck dissection (CND) on the recurrence of papillary thyroid cancer: potential role of BRAF^V600E mutation in defining CND[J]. Endocr Relat Cancer, 2013, 20(1): 13-22.
[7]	Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J]. Thyroid, 2016, 26 (1): 1-133.
[8]	Flockhart RJ, Webster DE, Qu K, et al. BRAF^V600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration[J]. Genome Res, 2012, 22(6): 1006-1014.
[9]	Fan Y-H, Ye M-H, Wu L, et al. BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta-analysis[J]. Oncotarget, 2017, 8(4): 6295-6303.
[10]	Shen XG, Bai YF, Luo B, et al. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer[J]. Biol Res, 2017, 50(1): 32.
[11]	Zhou T, Gao YJ. Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma[J]. World J Surg Oncol, 2016, 14(1): 8.
[12]	Liu ZH, Yang TX, Xu ZP, et al. Long non-coding RNA BANCR expression in esophageal squamous cell carcinoma and its effects on cell growth and invasion[J]. Progress in Modern Biomedicine, 2016, 16(24): 4622-4627.
[13]	Lou KX, Li ZH, Wang P, et al. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion[J]. Eur Rev Med Pharmacol Sci, 2018, 22(5): 1358-1365.
[14]	Zheng HT, Xu J, Hao SL, et al. Expression of BANCR promotes papillary thyroid cancer by targeting thyroid stimulating hormone receptor[J]. Oncol Lett, 2018, 16(2): 2009-2015.
[15]	Sun M, Liu X-H, Wang K-M, et al. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition[J]. Mol Cancer, 2014, 13: 68.
[16]	Shi YG, Liu YC, Wang JR, et al. Downregulated Long Noncoding RNA BANCR Promotes the Proliferation of Colorectal Cancer Cells via Downregualtion of p21 Expression[J]. PLoS One, 2015, 10(4): e0122679.
[17]	Liao T, Qu N, Shi RL, et al. BRAF activated lncRNA functions as a tumor suppressor in papillary thyroid cancer[J]. Oncotarget, 2017, 8(1): 238-247.
[18]	刘涛，赵艳红，王利萍，等．丝氨酸/苏氨酸蛋白激酶激活的长链非编码RNA对甲状腺癌细胞凋亡和自噬行为的影响[J]．中南大学学报(医学版)，2018，43(7)：747-753.
[19]	郭苗，李王丽．甲状腺乳头状微小癌的病理特征与BANCR表达的相关性[J]．实用癌症杂志，2019，34(7)：1060-1063.
[20]	顾姣姣，严威，王源源，等．长链非编码RNA-BANCR对甲状腺癌细胞迁移和侵袭的影响[J]．中华实验外科杂志，2019，36(9)：1625.
[21]	Wang YY, Gu JJ, Lin XD, et al. lncRNA BANCR promotes EMT in PTC via the Raf/MEK/ERK signaling pathway[J]. Oncol Lett, 2018, 15(4): 5865-5870.
[22]	Zhang JJ, Du YY, Zhang XX, et al. Downregulation of BANCR Promotes Aggressiveness in Papillary Thyroid Cancer via the MAPK and PI3K Pathways[J]. J Cancer, 2018, 9(7): 1318-1328.
[23]	Liu TR, Men QQ, Su X, et al. Downregulated expression of TSHR is associated with distant metastasis in thyroid cancer[J]. Oncol Lett, 2017, 14(6): 7506-7512.
[24]	郝少龙，刘新承，马纪红，等．甲状腺乳头状癌组织TSHR表达与BRAF^V600E基因突变的关系研究[J/CD]．中华普外科手术学杂志(电子版)，2018，12(6)：468-471.
[25]	Zheng HT, Wang M, Jiang LX, et al. BRAF-activated long noncoding RNA modulates papillary thyroid carcinoma cell proliferation through regulating thyroid stimulating hormone receptor[J]. Cancer Res Treat, 2016, 48(2): 698-707.
[26]	Gugnoni M, Sancisi V, Gandolfi G, et al. Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy[J]. Oncogene, 2016, 36(5): 667-677.
[27]	Spoto G, Esposito A, Santoleri F, et al.Does cyclic guanosine monophosphate induce autophagy in thyroid malignant carcinoma through down-regulation of cyclic guanosine monophosphate phosphodiesterase？[J]. J Biol Regul Homeost Agents, 2016, 30(2): 599-604.
[28]	Wang Y, Guo QH, Zhao Y, et al. BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma[J]. Oncol Lett, 2014, 8(5): 1947-1952.

Please choose a citation manager

Content to export